Atropine Sulfate Injection, USP

About Medefil

Medefil is a private, commercial-stage specialty pharmaceutical company with a 25-year history, initially built on manufacturing prefilled flush syringes. It has evolved into a fully integrated developer and manufacturer of generic injectable drugs, leveraging state-of-the-art R&D and manufacturing infrastructure. The company's strategy targets critical and complex injectables with supply shortages or development challenges, aiming to provide reliable, cost-effective alternatives. With over one billion prefilled syringe units supplied and a growing portfolio of ANDA-approved products, Medefil is positioned in the resilient generic injectables market.

Therapeutic Areas